Zobrazeno 1 - 10
of 355
pro vyhledávání: '"Stephan Madersbacher"'
Autor:
Thorben Winkler, Christoph A J von Klot, Stephan Madersbacher, Markus A Kuczyk, Mathias Wolters
Publikováno v:
PLoS ONE, Vol 18, Iss 1, p e0279883 (2023)
ObjectiveRezum is a minimal invasive surgical treatment for patients with lower urinary tract symptoms (LUTS) related to benign prostatic enlargement (BPE). The aim of our study was to assess safety and efficacy of the Rezum procedure in a consecutiv
Externí odkaz:
https://doaj.org/article/e703743d582b438a98b0a1fb8da1d231
Autor:
Gennadi Tulchiner, Nina Staudacher, Josef Fritz, Monika Hackl, Martin Pichler, Maximilian Seles, Shahrokh F. Shariat, David D’Andrea, Kilian Gust, Walter Albrecht, Karl Grubmüller, Stephan Madersbacher, Sebastian Graf, Lukas Lusuardi, Herbert Augustin, Andreas Berger, Wolfgang Loidl, Wolfgang Horninger, Renate Pichler
Publikováno v:
Cancers, Vol 13, Iss 21, p 5377 (2021)
We conducted a retrospective National Cancer Registry study in Austria to assess a possible seasonal variation in the clinical diagnosis of testicular germ cell tumors (TGCT). In total, 3615 testicular cancer diagnoses were identified during an 11-ye
Externí odkaz:
https://doaj.org/article/d59ed494bb56415da028d81b3f9e5963
Publikováno v:
Andrology.
BACKGROUND: Given the paucity of literature on the end of life (EOL) of prostate-cancer (PC) patients, we investigated medication prescription pattern and hospitalization during their final year of life. METHODS: The data base of the Österreichische
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e017b70e4544471cd875a02a4bf6ea35
https://doi.org/10.21203/rs.3.rs-2625881/v1
https://doi.org/10.21203/rs.3.rs-2625881/v1
Autor:
Martin C. Michel, Stephan Madersbacher
Publikováno v:
Aktuelle Urologie. 53:240-245
ZusammenfassungAuch Jahrzehnte nach der Einführung der 5α-Reduktasehemmer und der α1-Adrenozeptor-Antagonisten ergeben sich praxisrelevante, neue Daten zu deren erwünschten und unerwünschten Wirkungen. Einige der neuen Befunde sind ihrer Natur n
Autor:
Stephan Madersbacher
Publikováno v:
Benign Prostate Syndrome ISBN: 9783662670569
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7fd7707085cb73183399f9c731a9b15
https://doi.org/10.1007/978-3-662-67057-6_3
https://doi.org/10.1007/978-3-662-67057-6_3
Autor:
A. Henning, Stephan Madersbacher, Klaus Eredics, S. Sevcenco, Lukas Lusuardi, C. Falkensammer, M. Horetzky, Thomas Kunit, M. Rauchenwald, M. Marszalek, C. Wehrberger, U. Stoces
Publikováno v:
Prostate Cancer and Prostatic Diseases. 25:302-305
BACKGROUND Water vapor thermal therapy (Rezūm) is a minimally invasive treatment for benign prostatic enlargement (BPE). We report on safety and efficacy of this method for treatment of recurrent urinary retention and relief of catheter dependency o
Publikováno v:
Journal für Urologie und Urogynäkologie/Österreich. 28:97-102
Der demografische Wandel fuhrt zu einem erheblichen Anstieg an geriatrischen Patient*innen. Uber den urologischen Verlauf von hochbetagten Patient*innen ist wenig bekannt. Deshalb fuhrten wir eine retrospektive Studie an uber 90-Jahrigen, die auf ein
Autor:
Michael Lotterstätter, Stephan Seklehner, Florian Wimpissinger, Jozsef Gombos, Jasmin Bektic, Philipp Stolzlechner, Sarah Laimer, Thomas R. W. Herrmann, Stephan Madersbacher, Lukas Lusuardi, Manuela Sieberer, Christian Ramesmayer
Publikováno v:
World journal of urology. 40(12)
Purpose To determine the safety and efficacy of transurethral resection of the prostate (TUR-P) in patients 85 years or older. Methods In this retrospective, multicentre study, patients equal or older than 85 years at the time of surgery (2015–2020
Autor:
Jean-Nicolas Cornu, Cosimo De Nunzio, Ferdinando Fusco, Benjamin M. Brucker, Marcus J. Drake, Matthias Oelke, Benoit Peyronnet, Stavros Gravas, Stephan Madersbacher, Gommert van Koeveringe, Thomas Bschleipfer, Manuela Tutolo
Publikováno v:
European Urology
European Urology, Elsevier, 2021, ⟨10.1016/j.eururo.2020.12.032⟩
European Urology, Elsevier, 2021, ⟨10.1016/j.eururo.2020.12.032⟩
Context: The role of overactive bladder (OAB) treatment in women beyond antimuscarinics has been evaluated extensively. Beta-3 agonists, botulinum toxin-A (BTX-A), and nerve stimulation are indicated in these patients. However, data on male patients